Total arterial revascularization on beating heart: experience in 803 cases

Sushil Kumar Singh1, Surya Kumar Mishra, Deepak Kumar

  • 1Department of Cardiology & Cardiothoracic Surgery, Batra Hospital & Medical Research Centre, M.B. Road, New Delhi 110 0062, India.

Insights

Total arterial revascularization on the beating heart is a safe and effective procedure for coronary artery bypass grafting. This study of 803 patients shows excellent graft patency and minimal morbidity, avoiding cardiopulmonary bypass complications.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Interventional Cardiology

Background:

  • Cardiopulmonary bypass can lead to adverse effects.
  • Total arterial revascularization aims to mitigate these risks.
  • Beating heart surgery offers an alternative approach.

Purpose of the Study:

  • To evaluate the safety and efficacy of total arterial revascularization on the beating heart.
  • To assess short-term outcomes, including graft patency and morbidity.
  • To determine the reproducibility of the procedure in a large, unselected patient cohort.

Main Methods:

  • Prospective study of 803 patients undergoing total arterial revascularization on a beating heart.
  • Utilized an Octopus stabilizer for myocardial stabilization.
  • Included various arterial grafts: internal mammary and radial arteries.
  • Assessed outcomes including operative mortality, stroke, renal impairment, blood transfusion rates, hospital stay, and angiographic patency.

Main Results:

  • Operative mortality was low at 0.5%.
  • No postoperative strokes and minimal renal impairment were observed.
  • 558 patients (69%) did not require blood transfusions.
  • Mean hospital stay was 5.6 days.
  • Overall angiographic graft patency was high at 98.6%.

Conclusions:

  • Total arterial revascularization on the beating heart is a safe, effective, and reproducible technique.
  • The procedure demonstrates excellent short-term graft patency and minimal patient morbidity.
  • This approach is suitable for a wide range of patients, including those with complex coronary artery disease and reduced ejection fraction.

Related Concept Videos